Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China · Delayed Price · Currency is CNY 5.09
+0.04 (0.79%)
Jul 10, 2026, 3:00 PM CST
SHA:600713 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,662 | 7,147 | 6,494 | 6,342 | 6,709 | 5,114 | |
Market Cap Growth | -1.55% | 10.05% | 2.41% | -5.47% | 31.18% | 10.34% |
Enterprise Value | 18,710 | 18,873 | 17,415 | 18,818 | 16,766 | 14,628 |
Last Close Price | 5.09 | 5.28 | 4.64 | 4.36 | 4.50 | 4.21 |
PE Ratio | 12.29 | 11.44 | 11.38 | 10.98 | 11.26 | 10.12 |
Forward PE | - | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 |
PS Ratio | 0.12 | 0.13 | 0.12 | 0.12 | 0.13 | 0.11 |
PB Ratio | 0.79 | 0.87 | 0.83 | 0.87 | 1.00 | 0.98 |
P/TBV Ratio | 0.94 | 1.03 | 0.99 | 1.03 | 1.18 | 1.20 |
P/FCF Ratio | - | - | 4.08 | 3.63 | - | 13.15 |
P/OCF Ratio | - | 77.84 | 3.04 | 3.33 | - | 7.36 |
EV/Sales Ratio | 0.34 | 0.34 | 0.32 | 0.35 | 0.33 | 0.32 |
EV/EBITDA Ratio | 11.63 | 12.63 | 10.30 | 11.38 | 10.87 | 10.10 |
EV/EBIT Ratio | 13.81 | 14.00 | 11.33 | 12.55 | 12.07 | 11.25 |
EV/FCF Ratio | - | - | 10.95 | 10.76 | - | 37.63 |
Debt / Equity Ratio | 1.56 | 1.14 | 1.31 | 1.26 | 1.83 | 1.89 |
Debt / EBITDA Ratio | 8.19 | 5.84 | 5.65 | 5.15 | 7.41 | 6.40 |
Debt / FCF Ratio | - | - | 6.41 | 5.21 | - | 25.38 |
Net Debt / Equity Ratio | 1.29 | 0.74 | 0.72 | 0.93 | 1.48 | 1.49 |
Net Debt / EBITDA Ratio | 7.30 | 4.09 | 3.33 | 4.08 | 6.41 | 5.37 |
Net Debt / FCF Ratio | -6.23 | -38.30 | 3.54 | 3.85 | -11.81 | 19.99 |
Asset Turnover | 1.58 | 1.77 | 1.82 | 1.79 | 1.75 | 1.83 |
Inventory Turnover | 7.65 | 7.82 | 8.33 | 8.68 | 9.12 | 9.83 |
Quick Ratio | 1.08 | 1.06 | 1.16 | 1.00 | 0.97 | 0.99 |
Current Ratio | 1.45 | 1.53 | 1.63 | 1.40 | 1.31 | 1.34 |
Return on Equity (ROE) | 10.06% | 10.38% | 9.88% | 10.22% | 12.00% | 12.15% |
Return on Assets (ROA) | 2.46% | 2.71% | 3.25% | 3.12% | 3.02% | 3.30% |
Return on Invested Capital (ROIC) | 5.72% | 6.98% | 8.31% | 7.15% | 7.42% | 7.57% |
Return on Capital Employed (ROCE) | 10.40% | 10.40% | 11.30% | 15.20% | 14.80% | 15.60% |
Earnings Yield | 9.34% | 8.74% | 8.79% | 9.11% | 8.88% | 9.88% |
FCF Yield | -26.35% | -2.23% | 24.50% | 27.57% | -12.48% | 7.60% |
Dividend Yield | 3.34% | 3.22% | 3.66% | 3.67% | 3.11% | 2.85% |
Payout Ratio | 41.05% | 78.84% | 88.47% | 101.75% | 81.07% | 185.06% |
Buyback Yield / Dilution | -14.84% | -12.58% | -0.33% | -3.54% | -20.39% | 0.10% |
Total Shareholder Return | -11.47% | -9.37% | 3.33% | 0.12% | -17.29% | 2.96% |